Inventor · disambiguated record
Zhao Xu
Also filed as: XU ZHAO · XU ZHAO-YANG
5 granted patents·10 pending applications·7 citations·filing 2012–2025
71Inventor score
Files withARROWHEAD PHARMACEUTICALS INC9FUNDAMENTA THERAPEUTICS INC2FUNDAMENTA THERAPEUTICS CO LTD1HEWLETT PACKARD DEVELOPMENT CO1JIANG HONGSHAN1
Top patents by PatentIndex Score
15 records- 0192US11629349B2RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Apr 18, 2023·3 cites·14 claims
- 0292US11549112B1RNAi agents for inhibiting expression of xanthine dehydrogenase (XDH), pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Jan 10, 2023·3 cites·14 claims
- 0386US11845937B2RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2023·Granted Dec 19, 2023·1 cites·22 claims
- 0476US2023139166A1RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0576US2023125671A1RNAi Agents for Inhibiting Expression of Xanthine Dehydrogenase (XDH), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0675US2025034577A1RNAi Agents for Inhibiting Expression of PNPLA3, Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0766US12054718B2RNAi agents for inhibiting expression of PNPLA3, pharmaceutical compositions thereof, and methods of useARROWHEAD PHARMACEUTICALS INC·Filed 2021·Granted Aug 6, 2024·0 cites·34 claims
- 0860US2023013022A1RNAi Agents for Inhibiting Expression of Beta-ENaC, Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0959US2025376688A1RNAi Agents for Inhibiting Expression of Proprotein Convertase Subtilisin Kexin 9 (PCSK9), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1055US2022340639A1Allogeneic car-t cell, preparation therefor, and application thereofFUNDAMENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1153US2022313736A1Allogeneic car-t cell, preparation therefor, and application thereofFUNDAMENTA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1248US2023172980A1Chimeric Antigen Receptor, Construction Method Therefor and Application ThereofFUNDAMENTA THERAPEUTICS CO LTD·Filed 2020·Application pending·0 cites
- 1344US2012330559A1Systems and methods for hybrid assembly of nucleic acid sequencesJIANG HONGSHAN·Filed 2012·Application pending·0 cites
- 1436US2017197937A1New crystal form of pantoprazole sodium compound and preparation method thereforUNIV TIANJIN·Filed 2015·Application pending·0 cites
- 1535US11539850B2Printer including copy and scan functionsHEWLETT PACKARD DEVELOPMENT CO·Filed 2016·Granted Dec 27, 2022·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Zhao Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →